AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases

Investigative Ophthalmology & Visual Science, 53(4), pp.2170-2180

Published Date

2012-01-01

Associated Team Member

2012

01

Oliner, J.D., Bready, J., Nguyen, L., Estrada, J., Hurh, E., Ma, H., Pretorius, J., Fanslow, W., Nork, T.M., Leedle, R.A. and Kaufman, S., 2012

Investigation Type

Development Phase

Therapy Class